| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006056433A2 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116301 Liquid phenolic sulphur-containing antioxidants |
| 06/01/2006 | US20060113530 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 06/01/2006 | CA2586520A1 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 05/31/2006 | EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 05/31/2006 | EP1660436A1 Cathepsin inhibitors |
| 05/31/2006 | EP1660433A2 Preparation and use of alkylating agents |
| 05/31/2006 | EP1660431A2 Phenoxyacetic acid derivatives |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660137A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780815A Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053240 Process for synthesizing disulfides |
| 05/30/2006 | US7053235 for forming a unit molecular film as a rectifier |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/30/2006 | CA2263663C Substituted gamma aminobutyric acids as pharmaceutical agents |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/26/2006 | WO2006002361A3 2-methylpropanamides and their use as pharmaceuticals |
| 05/25/2006 | US20060111445 Novel carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1499587A4 Process for synthesizing pharmaceutically active disulfide salts |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1097130B1 Method for preparing hydroxymethylthiobutyric acid |
| 05/24/2006 | CN1777812A Modulators of the G protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775750A One-step method for synthesizing pyridaben by nucleo philic substitution reaction |
| 05/24/2006 | CN1775741A Garlic total amino acid and other salt-base substances extracting process |
| 05/24/2006 | CN1257156C Process for the preparation of thiophenols |
| 05/24/2006 | CN1257153C Novel propargylether derivatives |
| 05/23/2006 | US7049459 Chemical intermediate for rofecoxib, cyclooxygenase inhibitor |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2006051314A2 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | WO2006036795A8 A compound, a molecular switch employing the compound and a method of electronic switching |
| 05/18/2006 | US20060106105 Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy] butyric acid |
| 05/18/2006 | US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105435 Process for producing optically active alpha-methylcysteine derivative |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/17/2006 | EP1657288A1 2-Hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents |
| 05/17/2006 | EP1656344A1 Maillard reaction compounds of cysteine and a sugar having meatlike flavour |
| 05/17/2006 | EP1656127A1 Compounds for the treatment of metabolic disorders |
| 05/17/2006 | EP1519917A4 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 05/17/2006 | CN1772749A Fungicides for the control of take-all disease of plants |
| 05/17/2006 | CN1772732A Antifungal compound and its prepn process and application |
| 05/16/2006 | US7045665 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 05/16/2006 | US7045663 Comprises enantiomrph of ajoene such as Z(-)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide for treating tissues/ improving condition for transplantation; gene expression inhibition; kits |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045649 compounds are suitable, for example, for use as anorectics |
| 05/16/2006 | US7045621 Process for producing dibenzothiazepine derivatives |
| 05/16/2006 | US7045558 Method of making a high refractive index optical management coating and the coating |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045512 Controlling fungi in plants, seeds |
| 05/16/2006 | CA2291650C Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same |
| 05/16/2006 | CA2242571C Amino compounds and angiotensin iv receptor agonists |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/11/2006 | WO2006049321A1 Compound, polymerizable composition, optical device, and method for producing refractive index profile optical device |
| 05/11/2006 | WO2006032023A3 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/11/2006 | US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid |
| 05/11/2006 | CA2575764A1 Diaryl ureas as cb1 antagonists |
| 05/10/2006 | EP1655280A1 Dicarboxylic acid derivates with pharmaceutical properties |
| 05/10/2006 | EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 05/10/2006 | EP1654220A1 Compounds for modulating cell proliferation |
| 05/10/2006 | EP1654213A1 Matrix metalloproteinase inhibitors |
| 05/10/2006 | EP1265838B9 Novel fatty acid analogous |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | CN1771221A Process for the production of 2-hydroxy-4-methylthiobutyric acid ammonium salt |
| 05/10/2006 | CN1255377C Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/09/2006 | US7041853 Process for producing 4-bromothioanisole |
| 05/09/2006 | US7041851 Diagnosis; central nervous system disorders; psychological disorders |
| 05/09/2006 | US7041844 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | WO2006046736A1 Thiol compound and photosensitive composition using the same |
| 05/04/2006 | WO2006012227A3 Amido compounds and their use as pharmaceuticals |
| 05/04/2006 | WO2005080325A3 Sulfur-containing compositions and processes for making same |
| 05/04/2006 | US20060094786 Treating syndrome X with substituted tetralins and indanes |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/03/2006 | EP1651596A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651203A1 Quinoneimines of malonic acid diamides |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | CN1254465C Calcilytic compounds |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7037939 Compound and derivative of gabapentin |
| 05/02/2006 | US7037938 For therapy of urinary incontinence |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |